While most differences in peoples' genomes - called variants - are harmless, some are beneficial, while others contribute to diseases and conditions, ranging from cognitive disabilities to susceptibilities to cancer, obesity, diabetes, heart disease and other disorders.
Understanding how genomic variants contribute to disease may help clinicians develop improved diagnostics and treatments, in addition to new methods of prevention.
An international team of researchers in the US, UK, China, Germany and Canada from the 1000 Genomes Project Consortium examined the genomes of 2,504 people from 26 populations across Africa, East and South Asia, Europe and the Americas.
The catalogue more than doubles the number of known variant sites in the human genome, and can now be used in a wide range of studies of human biology and medicine, providing the basis for a new understanding of how inherited differences in DNA can contribute to disease risk and drug response.
Of the more than 88 million variable sites identified, about 12 million had common variants that were likely shared by many of the populations.
"The 1000 Genomes Project was an ambitious, historically significant effort that has produced a valuable resource about human genomic variation," said Eric Green director of The National Human Genome Research Institute (NHGRI), part of the US National Institutes of Health.
"The latest data and insights add to a growing understanding of the patterns of variation in individuals' genomes, and provide a foundation for gaining greater insights into the genomics of human disease," Green said.
They found nearly 69,000 differences, known as structural variants. These genomic differences, many of which affected genes, include deletions (loss of DNA), insertions (added DNA), and duplications (extra DNA copies).
The researchers created a map of eight classes of structural variants that potentially contribute to disease.
